OUR TEAM
We are a collaborative, established team of field-leading scientists, medical professionals, and data pioneers with specialties in children's health, toxicology and Artificial Intelligence discovery.
Alan Hoberman, Ph. D
Director of Toxicology
Alan joined Tio as the Director of Toxicology, from his role as Executive Director of Global Developmental, Reproductive and Juvenile Toxicology at Charles River Labs. Alan is a Diplomat of the American Board of Toxicology and Fellow of the Academy of Toxicological Sciences, with over 100 publications and book chapters.
Mark E. Hurtt, Ph. D
Chief Scientific Officer
Mark is the Chief Scientific Officer and Tio's company lead for developmental and reproductive toxicology. Mark joins Tio after leading global developmental toxicology for Pfizer.
Max R. Langham, MD
Chief Executive Officer
Max is co-founder and CEO of Tio. Max has his career as a leader in his field focusing on improving clinical outcomes for children as a pediatric surgeon, academia, and clinical process redesign. He has a track record of success as a collaborative leader for complex projects
Kevin Matlock
Director of Engineering
Kevin is the Director of Engineering for Tio. He is a computer scientist with X years of experience. He is an expert in image storage, image interpretation, and visual models. Kevin brings an extensive background in causal AI to Tio.
Ganapati Srinivasa
Chief Technology Officer
'Gans' is a co-founder of Tio and the CIO of Tio. An artificial intelligence pioneer, Gans has extensive experience leading multi-disciplinary teams towards complex technological software design goals.
